Efecto del tamaño de partícula y tipo de amonificación-conservación sobre la digestibilidad in vivo y consumo de rastrojos de maíz, en ovinos

a P P e n D i X D

donor testing The laboratory tests and measurements done on a donor or donor specimen to determine: • if the donor has or ever had a transmissible disease or is or ever was infected with a transmissible disease agent, • donor compatibility, and

• the degree of functionality of the cell, tissue or organ that is to be retrieved.

end-user The physicians/surgeons or dentists who transplant tissues and organs for the benefit of recipients. eye bank An establishment that recovers, processes and/or distributes ocular tissue.

Histocompatibility laboratory (or HlA or tissue typing laboratory) A laboratory that performs HLA tissue typing of donors and recipients, and cross-match testing to determine the degree of compatibility between donor and recipient.

Human leukocyte Antigen (HlA) The major antigen compatibility complex in humans that is genetically determined and is involved in cell self-identification. These protein molecules can provoke an immune response and the development of antibodies. If the recipient has preformed antibodies to the donor’s HLA type, there is a risk of rejection of the graft or organ.

Highly sensitized patient (Hsp) A patient who has been exposed to foreign tissue either through previous transfusions, transplantation or pregnancy, and who has developed antibodies against many common Human Leukocyte Antigen (HLA) molecules. As a result, the majority of organs that become available are incompatible and cannot be transplanted to these patients.

intensivist A physician with training in critical-care medicine.

leading practices Methods and techniques that have consistently shown results superior to those achieved with other means. Leading practices are used to guide medical practice and decision-making in the absence of evidence based research; for example, effective procedures requesting consent for donation. listing The process for placing an individual on a waitlist to receive an organ or tissue transplant, and for managing that individual’s rank and status on the waitlist.

living donor paired exchange (ldpe) Frequently, healthy and motivated people are unable to be living kidney donors for their spouses, relatives or friends because their blood group or tissue type is incompatible with the intended recipient. In a paired exchange, these live donors—healthy people who donate one of their two kidneys—are matched with other compatible recipients. Once an acceptable match is made, transplantations can occur between two sets of kidney donors and recipients.

neurological determination of death (ndd) The process and procedure for determining death of the individual based on neurological or brain-based criteria.

organ procurement organization (opo) An organization that is responsible for the facilitation of cell, tissue or organ donation (procurement), retrieval and distribution. This includes:

• receiving referrals for donation,

• collecting the information necessary to determine the suitability of the donor and their cells, tissues or organs,

• offering the cells, tissues or organs to the appropriate transplant program, • coordinating the retrieval of cells, tissues or organs,

• preserving, storing, transporting, releasing and delivering the cells, tissues or organs to the transplant program, and

a P P e n D i X D

potential donor Someone who has died and for whom consent for donation has been obtained, or someone who is alive and has been approved for donation.

processing In respect to tissues , any of the following activities: • Donor screening

• Donor testing

• Donor suitability assessment

• Testing and measurements after retrieval • Preparation for use in transplantation • Preservation

• Storing

• Packaging and labeling

Quality Management program A program that defines the policies and environment that are required to meet standards of quality and safety and that provides confidence that the processes and tissue consistently conform to requirements for quality.

recipient A person who receives a transplant.

regulations Laws, rules or orders prescribed by authorities to govern the behaviour of its citizens and organizations.

recovery The dissection and surgical removal of cells, tissues or organs from a living or deceased donor. specialized tissue products Tissue allografts that are more extensively processed than the allografts currently processed in Canada.

standard An established norm or requirement, described in a formal document, that sets out technical specification or other criteria that a product, process or service must meet; for example, CSA standards, and Accreditation Canada standards.

surgical bone bank An establishment that processes and/or distributes femoral heads obtained from living donors.

surveillance Monitoring of cell, tissue and organ receipients for undesirable responses or outcomes related to the transplant including the transmission of a disease or disease agent.

tissue A functional group of cells. Tissues may be transplanted as viable cells or otherwise preserved or fixed. Examples include ocular, musculoskeletal, cardiac, connective tissue (fascia), skin and amniotic membrane. Tissues do not include perfusable organs for transplantation.

tissue bank An establishment that recovers, processes and/or distributes musculoskeletal, cardiac, vascular, skin, amniotic membrane and/or soft tissue.

traceability The ability to locate tissues or organs at all stages in the process, from initial recovery from a donor through to either transplantation or disposal.

transplant follow-up The process of monitoring and evaluating the ongoing health and organ or tissue function of transplant recipients.

a P P e n D i X D

a c R o n Y m s

AAtB American Association of Tissue Banks AdM Acellular Dermal Matrix

ccdt Canadian Council for Donation and Transplantation ciHi The Canadian Institute for Health Information corr Canadian Organ Replacement Register csA Canadian Standards Association cto Cells, tissues, organs

dBM Demineralized bone matrix

dcd Donation after cardiocirculatory death eBAA Eye Bank Association of America

er Emergency room

HlA Human Leukocyte Antigen Hsc Health Science Centre Hsp Highly sensitized patient icU Intensive care unit

ldpe Living donor paired exchange lHin Local health integration networks ndd Neurological determination of death odt Organ donation and transplantation opo Organ procurement organization or Operating room

otdt Organ and tissue donation and transplantation pHAc Public Health Agency of Canada

tdt Tissue donation and transplantation Unos United Network for Organ Sharing

s e c t i o n n a m e | section name

Canada’s Organ Donation and Transplantation Community Canada’s Tissue Donation and Transplantation Community Canadian Blood Services

Canadian Blood Services assumes no responsibility or liability for any consequences, losses or injuries, foreseen or unforeseen, whatsoever or howsoever occurring, which might result from the implementation, use or misuse of any information or recommendations in Call to Action: A Strategic Plan to Improve Organ and Tissue Donation and Transplantation Performance in Canada . The views expressed herein do not necessarily represent the views of Canadian Blood Services and/or the federal, provincial or territorial governments of Canada .

Production of Call to Action has been made possible through financial contributions from Health Canada and the provincial and territorial ministries of health (except Quebec) .

For more information please contact: Canadian Blood Services Organs and Tissues Donation and Transplantation

1800 Alta Vista Drive Ottawa, ON K1G 4J5 Phone: 613 739-2300